Whistleblower Receives $3.9 Million for Revealing Medicare Fraud
On December 18, the Justice Department announced that drug company Biogen, Inc., agreed to pay $22 million to settle a False Claims Act case related to Medicare fraud. Charities Used to Hide Copay Kickbacks When a Medicare patient buys a prescription drug covered by Medicare, they may have to...